Loading company…
Durham-based gene therapy company developing treatments for life-threatening genetic disorders using its STRIVE capsid platform.
Founded in 2015 in Durham, US, by Aravind Asokan, StrideBio, Inc. develops gene therapies based on its STRIVE Capsid Platform, which improves delivery of adeno-associated virus vectors. It works mainly with pharmaceutical partners and research institutions in North America and Europe. In April 2023, the company raised USD 48.92 mn in Series B funding from a group including CaaS Capital Management and Novo Holdings.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in